Informations techniques
Exploitant
IDORSIA PHARMACEUTICALS FRANCE SAS
Présentation
QUVIVIQ 25 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 0 2)
QUVIVIQ 50 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 2 6)
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
vhkjun0DAuXQAu8P